NieminenMSBrutsaertDDicksteinKDrexlerHFollathFHarjolaV-P, et alEuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006; 27(22):2725-36.
2.
PonikowskiPAnkerSDAlHabibKFCowieMRForceTLHuS, et alHeart failure: preventing disease and death worldwide. ESC Heart Failure. 2014; 1(1):4-25.
PonikowskiPVoorsAAAnkerSDBuenoHClelandJGFCoatsAJS, et al2016ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27):2129-200.
5.
YoshihisaASatoTKajimotoKSatoNTakeishiY, Acute Decompensated Heart Failure Syndromes i. Heterogeneous impact of body mass index on in-hospital mortality in acute heart failure syndromes: An analysis from the ATTEND Registry. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 589–598.
6.
Montenegro SaFCarvalhoRRuivoCSantosLGAntunesASoaresF, et alBeta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 599–605.
7.
KajimotoKMinamiYOtsuboSSatoN, investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Association of admission and discharge anemia status with outcomes in patients hospitalized for acute decompensated heart failure: Differences between patients with preserved and reduced ejection fraction. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 606–614.
8.
LimSLChanSPLeeKYChingAHoldenRJMillerKF, et alAn East-West comparison of self-care barriers in heart failure. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 615–622.
9.
SatoYYoshihisaAOikawaMNagaiTYoshikawaTSaitoY, et alHyponatremia at discharge is associated with adverse prognosis in acute heart failure syndromes with preserved ejection fraction: a report from the JASPER registry. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 623–633.
10.
ChenDYLiCYHsiehMJChenCCHsiehICChenTH, et alPredictors of subsequent myocardial infarction, stroke, and death in stable post-myocardial infarction patients: A nationwide cohort study. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 634–642.
11.
CarvalhoLSFBogniottiLACde AlmeidaOLRJCQESNadruzWCoelhoOR, et alChange of BNP between admission and discharge after ST-elevation myocardial infarction (Killip I) improves risk prediction of heart failure, death, and recurrent myocardial infarction compared to single isolated measurement in addition to the GRACE score. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 643–651.
12.
PittBRemmeWZannadFNeatonJMartinezFRonikerB, et alEplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction. New England Journal of Medicine. 2003; 348(14):1309-21.
13.
IbanezBJamesSAgewallSAntunesMJBucciarelli-DucciCBuenoH, et al2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationThe Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2):119-77.
14.
Agra-BermejoRCorderoARodriguez-ManeroMGarcia AcunaJMAlvarez AlvarezBMartinezA, et alClinical impact of mineralocorticoid receptor antagonists treatment after acute coronary syndrome in the real world: A propensity score matching analysis. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 652–659.
15.
van DiepenSTranDTEzekowitzJASchnellGWileyBMMorrowDA, et alIncremental costs of high intensive care utilisation in patients hospitalised with heart failure. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 660–666.
16.
RosselloXGilVEscodaRJacobJAguirreAMartin-SanchezFJ, et alEditor's Choice- Impact of identifying precipitating factors on 30-day mortality in acute heart failure patients. Eur Heart J Acute Cardiovasc Care. 2019; 8(7): 667–680.
